How much revenue does Sunniva make?

Sunniva reported 18.79 million CAD in revenue for fiscal year 2018, up 16.9% from 16.07 million CAD in fiscal year 2017. In Q3 2019 revenue was 5.36 million CAD.

What companies are similar to Sunniva?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Kaleido Biosciences, Inc. (KLDO), ONE Bio Corp. (ONBI), Ember Therapeutics, Inc. (EMBT), Canntab Therapeutics Limited (CTABF).

Sunniva Inc. (SNNVF) Stock

About Sunniva Inc.

Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its products under the Sun Fire, Kyndness, and Herbella brands. The company was formerly known as Sunniva H...

At a glance

Sunniva reported revenue of 18.79 million CAD for fiscal year 2018, up 16.9% from fiscal year 2017, and net income of -29.05 million CAD. In Q3 2019 (the quarter ended September 30, 2019) revenue was 5.36 million CAD, up 353.6% from a year before.

Figures from company filings; latest fiscal year ended December 31, 2018.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.